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Abstract In the epidermis, the keratinocytes are the 
first cells to be encountered by external stimuli and 
they are able to promote the inflammatory response by 
increased production and release of various cytokines. 
In their turn, these cytokines may directly affect the 
production of proinflammatory cytokines in human 
dermal fibroblasts. In addition, in both epithelial and 
mesenchymal cells cytokine production may be modu­
lated by their mutual interaction, and thereby regulate 
the inflammatory response. The present study aimed 
to examine the role of fibroblasts in the regulation of 
proinflammatory IL-1, IL-6 and IL-8 levels induced 
by keratinocyte-derived IL-1. The data show that in 
fibroblasts exposed to conditioned media derived from 
cultures of normal human keratinocytes or squamous 
carcinoma cells (SCC-4), both the IL-8 and IL-6 
mRNA expression as well as protein production were 
elevated. In addition, it was shown that these effects
subsequent internalization and intracellular degrada­
tion is the most likely mechanism involved in the re­
duction of IL-1 levels by fibroblasts. Comparing the 
rate of IL-1 reduction in the presence of various cell 
types indicated that the rate of IL-1 reduction is di­
rectly related to the number of IL-1 receptors found 
on these cell types. In conclusion, these results indicate 
that the release of IL -la  by activated keratinocytes 
may act as an inducer of IL-8 and IL-6 production in 
neighbouring fibroblasts. This may be an important 
pathway for the amplification of the inflammatory re­
sponse. The amounts of both cytokines produced by fi­
broblasts were at least two to three orders of magni­
tude higher than those produced by keratinocytes, 
suggesting an important role of fibroblasts in the gen­
eral inflammatory response. Furthermore, fibroblasts 
might be involved in turning off this inflammatory re­
sponse by reducing IL-1 levels, most likely via IL-1 re-
were induced by IL -la . The IL-la-induced increase in ceptor-mediated uptake. 
IL-8 and IL-6 production, both on the protein level as
well as on the mRNA level, were concentration depen­
dent and occurred almost simultaneously. W hile the 
induction of IL-6 and IL-8 occurred simultaneously,
the IL-6 mRNA remained elevated for longer. In con- ------------------
trast to increased IL-6 and IL-8 production the IL - la  Introduction
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levels markedly decreased upon culturing o f fibro­
blasts in keratinocyte-derived conditioned medium. rr h e r e  is increasing evidence that the release and produc-
From internalization experiments it could be con- tion of cytokines, either preformed o.r newly synthesized, 
eluded that binding of IL-1 to IL-1 receptors, and its by keratinocytes and fibroblasts is altered after certain
events, such as skin injury [I], The keratinocytes become 
‘activated1 and release, amongst other things, the proin­
flammatory cytokine interleukin-1 (IL-1) |2 |. It has been 
shown that exposure of skin cells to IL-l leads to an in­
creased production of IL-6 and IL-8 [2-7 ], Proinflamma- 
tory cytokines, such as IL-8 and IL-6 are pleiotropic cy­
tokines and act on multiple cell types. In addition, both 
IL-8 and IL-6 are thought to play an important role in both 
the cellular and the humoral immune responses via differ­
ent pathways | 8 |. At low concentrations IL-8 possesses 
neutrophil, lymphocyte and basophil chemotactic proper­
ties, while at higher concentrations IL-8 can activate neu-
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trophils and T cells [9], The major effects of IL-6 with re­
spect to immune response are the stimulation of the final 
differentiation of B cells into antibody-producing plasma 
cells and the induction of acute phase proteins in hepato- 
cytes [10]. Since the humoral and cellular pathways are 
complementary, the presence of both IL-6 and IL-8 will 
potentiate the immune response.
We have recently shown that in keratinocyte-fibroblast 
cocultures, IL -la  derived from epidermal cells increases 
IL-6 production in fibroblasts [ 11]. It has been shown that 
the transcription factors NF-IL-6 and NF-kB are needed 
for IL-1-induced IL -6 and IL-8 gene expression [12]. The 
present study aimed to examine the kinetics of induction 
of IL-6 and IL-8 production in human dermal fibroblasts 
by conditioned medium derived from keratinocyte cul­
tures and by IL -la . We have previously reported that 
IL-1 activity is strongly reduced in cocultures of ker­
atinocytes and 3T3 fibroblasts [11). Since this might rep­
resent a negative feedback mechanism we further investi­
gated the processes involved in the reduction of IL-1 lev­
els by fibroblasts.
and the cells were 1 y se cl for RNÀ isolation. When antibodies against 
IL-1 were included in the experiment, HFF were incubated for 20 h 
in control medium or in a mixture of control medium and CM-SCC- 
4 or CM-NHK (4: 1 v/v), the latter two media were preincubated 
for 1 h at 37° C either in the absence or the presence of anti-IL-la 
and/or IL-Iß (kindly provided by S. Poole, National Institute for 
Biological Standards and Control, Potters Bar, UK). Supernatanls 
were harvested and stored at -20° C until use. Two independent 
experiments were performed for all conditions described above.
Determination of IL-6 and IL-1 bioactivity
IL-6 and IL-1 levels were determined using the B9 hybridoma 
growth assay [17] and DIO growth assay [18], respectively, using 
3-(4,5-dimethyithiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) 
for the determination of cell numbers [19]. The levels of IL-6 and 
IL-1 are expressed as picograms per millilitre by reference to stan­
dard curves obtained with recombinant human IL-6 or recombi­
nant human IL -la , respectively. All assays were performed in bi­
ological duplicate (two culture dishes per experimental condition) 
(n = 2) and the cytokine levels in the supernatanls were assayed in 
duplicate using five serial dilutions, Because the experiments were 
performed in duplicate no standard deviation is given. The internal 
variation of the mean values of the cytokine levels in the two inde­
pendent cultures did not exceed 13%.
Materials and methods
Cell culture
Human fibroblasts (HFF), derived from surgical specimens of fe­
male breast skin, and 3T3 cells were cultured in Dulbecco’s Mod­
ification of Eagle's Medium (DMEM) supplemented with 5% 
(v/v) fetal calf serum (FCS), penicillin (100 U/ml) ancî strepto­
mycin (100 pg/ml). Normal human keratinocytes (NHK) derived 
from juvenile foreskin and squamous carcinoma cells (SCC-4)
[13] were cultured using Die Rheinwald-Green feeder technique
[14], as described previously [15]*
Preparation of conditioned medium
HFF (1.25 x 10‘Vcm2) and SCC-4 were seeded as monocultures in 
DMEM/FI2 (3:1) supplemented with 5% (v/v) FCS, and the me­
dium was refreshed after 3 days. The supernatants (conditioned 
medium) of the 3-6-day culture period were collected and kept at 
- 20° C until use. To prepare conditioned medium of 3T3-free 
NHK monocultures, 1.25 x 10‘Vem2 NHK were seeded together 
with 1.8 x KV'/em* lethally irradiated 3T3 cells and grown to sub- 
con fluence in medium as described previously [15], Then 3T3 
cells were removed by 0.02% (w/v) eihyJenedianiinetelraacelic 
acid treatment |16| and NHK were then grown to confluence in 
DMEM/F12 (3:1) supplemented with 5% (v/v) FCS, NHK cul­
tures were then re fed with fresh medium and rei neu bated for 3 
days. This supernatant was collected and kept at -2 0 °C until use. 
For experiments, a mixture (1:1) of fresh and conditioned medium 
derived from HFF, SCC-4 and NHK was used. These media were 
termed CM-HFF, CM-SCC-4 and CM-NHK, respectively.
Stimulation of fibroblast cultures with either IL- l a  
or with conditioned medium in the presence or absence 
of antibodies against IL-1
Fibroblasts, HFF or 3T3 ceils were grown to confluence in DMEM/ 
FI 2 supplemented with 5%  (v/v) FCS. When HFF were exposed to 
conditioned medium the cells were incubated for 4, 8 and 24 h in 
CM-HFF, CM-SCC-4, CM-NHK or in control medium. For IL-1 
stimulation, the HFF were re fed with fresh medium. After 24 h 0, 
10 or 100 pg/ml IL -la  (Hoffman la Roche, Basel, Suisse) was added 
and the cells were reincubated for another 4, 8, 24 or 48 h. At var­
ious time points supernatanls were harvested and stored at —20°C
Determination of IL-1 antigen levels
IL - la  was measured using a radioimmunoassay (RIA) in which 
rabbit polyclonal antibodies to human recombinant IL~la were 
used. The detection limit was 5 pg IL-1 a/ml. This antibody did not 
crossreact with human IL-lß, IL-2, TNF, a-IFN, y-IFN, GM-CSF 
or C5a. The RIA was carried out as described by Lonnemann et al. 
[20] with minor modifications.
Determination of IL-8 levels
IL-8 was measured using an enzyme-linked immunosorbent assay 
(ELISA) in which monoclonal antibodies (MAbs) and polyclonal 
antibodies to human recombinant IL-8 were used, as described by 
Hack et al. 121]. The detection limit was 4 pg IL-8/ml. Standards 
and antibodies were a gift from Dr. L. A, Aarden (Red Cross Cen­
tral Laboratory for Blood Transfusion, Amsterdam, The Netherlands).
Analysis of mRNA
RNA was isolated according to the method of Chomczynski and 
Sacchi [22] and samples were analysed using the Northern blotting 
technique |23). cDNA probes specific for human JL-lß (443 bp), 
IL-6 (819 bp) and IL-8 (585 bp) were prepared by re verse-tran­
scriptase polymerase chain reaction [24] (kindly provided by Dr, 
R. A. tie Pans, Department of Haematology, Leiden, the Nether­
lands). Hybrid i/.at ion was performed as described by Quax el al. 
1251. The intensity of the bands of the autoradiograms was quanti­
fied photodensilomelrically (Desaga CD60) and normalized for to­
tal mRNA using 28S rRNA as a control (kindly provided by Dr. C. 
Backendorf, Leiden, The Netherlands).
IL-1 receptor binding assay
Triplicate confluent cultures of 3T3 cells and fibroblasts were 
washed twice with cold (0°C) ‘assay medium’ (DMEM containing
0.1% bovine serum albumin, buffered with 25 mM N-2-hydroxy- 
ethyl piperazine-N1-ethane su I phonic acid (HEPES), pH 7.4). The 
cells were then incubated in assay medium containing increasing 
amounts of 125I-IL-la  (0-4 ng/ml, specific activity 80 fiCi/jag) in 
the presence or absence of a 500-fold excess of nonlabelled IL-la. 
After a 5-h incubation at 4°C, the cells were washed twice with 
cold phosphate-buffered saline supplemented with 0.5% bovine
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serum albumin. The cells were then scraped and collected using a 
cotton-wool stick and total cell-associated radioactivity was deter­
mined. The number of molecules specifically bound to the cell sur­
face was determined after subtraction of 125l-IL-lcx bound in the 
presence of an excess of non label led IL-la. Sc ate hard analysis 
was performed in two independent experiments to determine the 
maximum number of binding sites and the Kd values.
Internalization and degradation of IL -la  was studied as de­
scribed by Van Oosterhout et al. [26]. Briefly, cells were incubated 
for various times at 37° C in the presence of !25I-lL-la. The cells 
were then treated or not treated with ice-cold isotonic glycine 
buffer (pH 2) for 10 min to discriminate between intracellular ac­
tivity and the total amount of associated radioactivity, respectively. 
Furthermore, 75 p-1 of culture supernatant was treated with 1 ml 
25% trichloroacetic acid (TCA) and 15 |il 1% bovine serum albu­
min at 4QC for 30 min, centrifuged at 18000 # Tor 15 min and the 
radioactivity in the supernatant and pellet determined. All experi­
ments (n =s 2) were performed in triplicate and each sample 
analysed in duplicate.
Results
Modulation of IL-8, IL-6 and IL-1 levels 
and mRNA expression in HFF
Effects o f conditioned media derived 
from epidermal cell cultures
The effects of conditioned media derived from epidermal 
cell cultures on the IL-8, IL-6 and IL-1 protein levels and
mRNA expression in HFF cultures were examined. Con­
fluent HFF cultures were incubated for various times in 
control medium or in the conditioned media CM-HFF, 
CM-NHK or CM-SCC-4, and the supernatanls were col­
lected and RNA was isolated.
When HFF were grown in CM-NHK or CM-SCC-4, 
levels of both IL-8 and IL-6 markedly increased with 
time (Fig, I a). The increase was more pronounced in 
HFF cultures grown in CM-SCC-4 than in CM-NHK. 
Exposure of HFF to CM-HFF did not affect either 
IL -6 or IL-8 production (data not shown). In contrast 
to increased IL-8 and IL-6 levels, IL-1 activity de­
creased within 24 h 'from 0.12 to 0,03 ng/ml in HFF 
grown in CM-NHK and from 0.4 to 0.3 ng/ml in HFF 
grown in CM-SCC-4. In HFF cultures grown for 24 h in 
control medium or in CM-HFF no IL-1 activity was de-
Northern blot analysis indicated that exposure of HFF 
to CM-SCC-4 and CM-NHK also resulted in an increase 
in IL-8 and IL-6 mRNA levels (Fig. 1 b). This increase 
persisted for longer in cells grown in CM-SCC-4 than in 
CM-NHK. Transiently elevated levels of IL-8 and IL-6 
mRNA were also observed in HFF grown in control me­
dium, probably resulting from medium renewal at the be­
ginning of the experiment. In addition, an increased ex­
pression of IL -1 ß mRNA was seen upon exposure of HFF 
to CM-SCC-4 and CM-NHK, No IL - la  mRNA could be
a
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detected either in stimulated or in nonstimulated cells 
(data not shown),
IL - la  present in supernatants derived from SCC-4 or 
NHK was found to be responsible for the observed in­
crease in IL-8 expression and production in HFF, since af­
ter preincubation of CM-NHK and CM-SCC-4 with anti­
bodies directed against IL - la  the IL-8 production in fi­
broblasts was markedly decreased (Table 1). The IL-8
Tabic 1 Effect of I L - la  and IL-lß antibodies on IL-8 production 
in fibroblasts induced by conditioned media derived from SCC-4 
and NHK cultures. HFF were cultured in medium supplemented 
with 5% FCS to confluence. The ceils were then incubated for 20 
h in control medium or in a mixture of control medium and CM- 
SCC-4 or CM-NHK (4:1 v/v), the latter two media were preincu­
bated for 1 h at 37° C either in the absence or in the presence of 
anti-IL-la  and/or anti-IL-lß. The supernatants were collected and 
IL-8 assayed using the IL-8 ELISA, Values are means ±  SD
Additives IL-8 levels (ng/ml)
Control
medium
CM-SCC-4 CM-NHK
None 0.08 5.04 ± 0.6 4.40 ± 1.1
A nti-IL-la 0.14 0.97 ±0,3 0.86 ± 0.1
Anti-IL-lß 0.14 5.42 ± 0.9 3.17 ±0.6
Anti-IL-1 a /ß 0.12 1.08 ± 0.2 0.72 ± 0.4
production was not affected by the neutralizing IL- 1 ß an­
tibody, indicating that there was hardly any IL-lß activity 
in CM-NHK or CM-SCC-4,
Effects of IL-1 a
We investigated whether the induction of the IL -8 and IL- 
6 production in HFF by supernatants derived from epider­
mal cultures was comparable to the effects induced by pu­
rified IL -la . HFF were exposed for various times to in­
creasing concentrations of IL -la , and the IL-8 and IL-6 
production was monitored. As shown in Fig. 2a, an in­
crease in IL-8 and IL-6 levels was observed in culture su­
pernatants derived from HFF exposed to IL -la . Concomi­
tantly with the increase in IL-8 and IL-6 levels, a reduc­
tion in IL-1 activity was observed in supernatants of HFF 
cultures exposed to IL -la , IL-1 activity decreased within 
48 h from the initial value of 100 pg/ml to 14 pg/ml., 
whereas at an initial concentration of 10 pg/ml, no IL-1 
activity could be detected after 24 h.
Changes in IL-8 and IL-6 mRNA expression in HFF 
exposed to IL -la  were also time- and concentration-de­
pendent. Delectable levels of IL-8 and IL-6 mRNA were 
measured as early as 4 h after stimulation of HFF with 10 
pg/ml IL -la  (Fig.2b). By prolongation of the incubation 
time to 24 h, the IL-8 mRNA expression decreased to un-
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Fig. 2 a b E ffee t of 1L -1 a  on 
the IL-8, IL-6 and IL-l levels 
and mRNA expression in HFF 
cultures. Confluent HFF cul­
tures were re fed with 20 ml 
fresh medium and after 24 h 
20 fxl IL-lcx was added to 
reach a final concentration of 
0, 10 or 100 pg/ml (O, •  and 
, respectively), a Super­
natants were collected after 
4, 8, 24 and 48 h after stimula­
tion and analysed for levels of 
IL-8, IL-6 and IL-1 as de­
scribed in Materials and meth­
ods. b RNA was isolated at the 
indicated time points and ana­
lysed using 32P-labelled cDNA 
probes for human IL-8, IL-6 , 
IL-lß and 28S rRNA
b
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Fig.3a-c Time course of the reduction in IL-1 protein, a Conflu­
ent 3T3 cultures were grown in control medium or CM-SCC-4 for 
4, 8 or 24 h, At the indicated time points supernatants were col­
lected and the IL-l levels determined by bioassay (O) and by ra­
dioimmunoassay (#), b, c Confluent 3T3 (b) and HFF (c) cultures 
were incubated with l25M L - la  (150 pg/ml) for the indicated times 
and In the supernatants collected. These supernatants were then 
treated with TCA, as described in Materials and methods. In the 
absence of fibroblasts (control) hardly any spontaneous degrada­
tion of l25I-IL-la  at 37° C was found (□  intact molecule, TCA in­
soluble; O degradation product, TCA soluble). In the presence of 
fibroblasts degradation of ,25I-IL -la  was observed (■  intact mol­
ecule, TCA insoluble; •  degradation product, TCA soluble). The 
standard deviation is given in c, but was usually smaller than the 
plot symbol
detectable levels, indicating that transcription of the IL-8 
gene was temporarily enhanced. In contrast, IL-6 mRNA 
expression remained elevated during the 24 h period. Af­
ter stimulation with 100 pg/ml IL -la , enhanced IL-8 
mRNA levels were detected for a longer period. Elevation 
in the IL-1 ß mRNA levels was observed only after stimu­
lation of HFF with 100 pg/ml IL -la  for 8 and 24 h. No 
IL -la  mRNA could be detected either in stimulated or in 
nonstimulated cells (data not shown),
Fibroblast-induced decrease in IL-1 protein levels
As described above, exposure of confluent cultures of hu­
man dermal fibroblasts to CM-SCC-4 (Fig, 1 a) or IL -la  
(Fig. 2 a) resulted in a decrease in IL-1 bioactivity. To ex­
amine whether this decrease was caused by the loss of IL- 
l a  protein, a RIA specific for human IL -la  was used. 
Since the decrease in IL - la  levels in the presence of 3T3 
cells is more rapid than with HFF | l l | ,  3T3 cells were 
used in these experiments. When 3T3 cells were exposed 
to CM-SCC-4, the time course of the reduction in IL-1 
iminunoreactivity closely paralleled the reduction in 
bioactivity (Fig. 3 a). Apparently the observed decrease in 
IL-1 bioactivity was not caused by mere transformation of 
IL-1 to its inactive form, but by a decrease in IL - la  pro­
tein levels. In addition, we found that in SCC-4/3T3 co- 
cultures the extracellular levels of imrnunoreactive and 
bioactive IL-l remained low, while in SCC-4 monocul­
tures both IL-1 immunoreaetivity and bioactivity in­
creased with time (data not shown).
8 16 
time (h)
24 0 24 48
time (h)
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To examine the reduction in IL-1 protein in the pres­
ence of fibroblasts in more detail, confluent HFF or 3T3 
cultures were incubated with l23I-IL -la  (150 pg/ml) for 
various times at 37° C and the radioactivity in the super­
natants present in TCA-soluble (degraded IL-l) and TCA- 
insoluble (intact IL-1) fractions were determined. In the 
presence of HFF the amount of degraded IL-1 increased 
within 78 h to 22,3 ± 1.5% of total added IL-1. The rate of 
IL-1 degradation was much higher in 3T3 cultures than in 
HFF (61.8 ± 0,7% versus 9.2 ± 2.3% after 24 h). Hardly 
any spontaneous degradation of l25I-IL -la  at 37°C was 
found in the absence of fibroblasts (4.6 ± 0,5% after 78 h). 
These findings were confirmed by running these super­
natants on an 18% SDS-PAGE gel followed by autoradi­
ography (data not shown).
It has been demonstrated that IL-1 can enhance the
production and secretion of proteolytic enzymes by fibro­
blasts [27]. Therefore, we further investigated whether 
degradation of IL-1 was due to enhanced proteolytic ac­
tivity. To this end l25l- IL -la  (600 pg/ml) was added to su­
pernatants derived from 3T3 cell and HFF cultures stimu­
lated or not with 1 ng/ml IL-1 for 20 h and incubated for 
20 h at 37° C  After TCA precipitation the distribution of 
the radioactivity over the two fractions was not signifi­
cantly different from the control (unconditioned medium). 
This indicates that there is no evidence for enhanced ex­
tracellular degradation, However, when 3T3 cells were 
first incubated with ,25I-IL -la  (5ng/ml) at 4°C, washed 
and subsequently incubated at 37° C, it could be shown 
that cell surface-bound IL - la  was rapidly internalized, 
degraded and excreted. As early as 1 h after the start of 
the experiment, detectable amounts of radioactivity were 
present in the supernatanls it) the TCA-soluble fraction; 
this amount increased to 85,7 ± 3.3% within 20 h (data not 
shown).
IL-1 receptor binding
Since the reduction in extracellular IL-1 levels occurs 
only in the presence of fibroblasts, presumably via IL-1 
receptor-mediated uptake [28, 29], the number of IL-1 
ing sites and Kd values were determined by 
Scatchard analysis. The results of these experiments re­
vealed that the number of IL-1 binding sites on 3T3 cells
396
18
15
r*'O
JS
w
12
9 -
6
Opq r
0 2.5 20 30 40 50 60 70
BOUND IL-1 (fmol/10 cells)
Fig. 4 Scatchard analysis of IL-1 binding to 3T3 cells and HFF. 
Increasing concentrations of 125l - IL - la  were incubated with cul­
tures of 3T3 cells ( • )  and HFF (O) in the presence or absence of 
a 500-fold excess of unlabelled IL - la  as described in Materials 
and methods. The data are plotted in the Scatchard format. The Kd 
obtained in the experiment was 60 pM  for both 3T3 cells and HFF, 
whereas the numbers of binding sites were approximately 38 x 103 
and 2.5 X 1G3, respectively
was more than 15 times higher than on HFF, approxi­
mately 38 X 10* and 2.5 X 103, respectively. This is in line 
with the observation that IL-1 degradation by 3T3 cells 
was more rapid than by HFF. The affinity of the receptors 
on both cell types for IL - la  was similar (approximately 
60 pM\ Fig. 4),
Discussion
There is increasing evidence for the existence of a com­
plex network of interacting cytokines mediating immune 
and inflammatory reactions in the skin [30, 31], Fibro­
blasts of the mesenchymal compartment and keratino­
cytes of the epithelial compartment participate actively 
and mutually in this network [32, 33]. IL-1 released from 
keratinocytes seems to play an important role in the initi­
ation of a cytokine cascade, because IL - la  derived from 
the keratinocytes is responsible for markedly enhanced 
IL-6 [11] and IL-8 (this study) production in fibroblasts. 
The present study further elucidates the mechanism of 1L- 
1, IL-6 and IL-8 modulation. It was shown that the protein 
and mRNA levels of both IL-6 and IL-8 increase almost 
simultaneously in a dose-dependent manner. The finding 
that both cytokines were induced simultaneously is in line 
with the results of a recent study by Matsusaka et al. [12] 
showing that the IL-I-induced gene transcription of both 
IL-6 and IL-8 is synergistically activated by similar tran­
scription factors, namely NF-IL-6 and NF-kB.
As was observed for IL-6 and IL-8 mRNA, IL -lß  
mRNA expression was also inducible in HFF by IL -la  in 
a dose-dependent fashion. The findings that total (added 
and secreted) bioactive IL-1 was reduced over time and
tion in HFF was not affected by the presence of a neutral­
izing antibody against IL-lß, strongly suggest that the 
amount of IL -lß  produced by fibroblasts was too low to 
exert an additional effect to exogenously administered IL-
l a .
In contrast to increased levels of IL-6 and IL-8 mea­
sured during the exposure of HFF to IL -la-containing 
media (conditioned media or IL-la-supplemented me­
dium), IL -la  bioactivity and immunoreactivity markedly 
decreased. The reduction in IL - la  levels can be fully as­
cribed to the action of fibroblasts, since in the absence of 
fibroblasts no spontaneous decrease in IL-1 protein was 
observed. Since this might represent a negative feedback 
mechanism we further investigated the processes involved 
in the reduction of IL-1 levels by fibroblasts. Various 
mechanisms may be responsible for the observed fibro­
blast-induced decrease in IL-1. The results of the present 
study show that it is unlikely that the decrease in IL-1 lev­
els is due to binding of IL-1 to an IL- l inhibitor [34], be­
cause the IL-1-inhibitor complex should have been de- 
tectëd in the RIA by the polyclonal antibody, which rec­
ognizes different epitopes on IL -la  [20] and such a com­
plex should be TCA-precipitable. It is also unlikely that 
the decrease in IL-1 activity is caused by an increase in 
IL-1 receptor antagonist [35-37], since the reduction in 
the IL-1 bioactivity paralleled a decrease in IL-1 im­
munoreactivity. Furthermore, we can exclude the involve­
ment of extracellular degradation of IL-1 by proteolytic 
enzymes, since 125I-IL-1 was not degraded when incu­
bated in the presence of supernatants derived from IL -1 - 
stimulated fibroblast cultures. We present evidence that 
125I-IL-1 was only degraded in the presence of fibroblasts 
by receptor-mediated uptake. A higher rate of reduction in 
IL-1 was observed in 3T3 cells as compared to HFF. This 
observation is in line with the 15-fold higher number of 
IL-1 receptors on 3T3 cells than on HFF. The affinity of 
the IL-1-receptor for IL-1 was similar in both cell types. 
The finding that the number of IL-1 binding sites on 3T3 
cells was higher than on HFF is in agreement with the re­
sults of Mizel et al. [28] and Akahoshi et al. [291. In line 
with the hypothesis that the fibroblast-regulated decrease 
in IL-1 levels may function as a negative feedback mech­
anism, is the observation that the disappearance of extra­
cellular IL-1 is paralleled by a decrease in IL-6 and IL-8 
mRNA expression in fibroblasts.
It is generally accepted that in the epidermis the ker­
atinocytes are the first cells to be encountered by external 
stimuli, initiating the immune response by increased pro­
duction of various cytokines. However, in comparison 
with the amounts of IL-1 produced and secreted by ker­
atinocytes, the production of IL-6 and IL-8 in these cells 
is very low [5, 11]. In contrast, fibroblasts produce 100 to 
1000 times more IL-6 and IL-8 than keratinocytes. There­
fore, the release of IL - la  by activated keratinocytes may 
act as an inducer of IL-8 and IL-6 production in neigh­
bouring fibroblasts, which may be a potent pathway for 
the amplification of the signal and initiation of a more 
general inflammatory response. On the other hand, fibro-
that the IL-l-induced stimulation of IL-8 or IL-6 produc- blasts may also be involved in the overall regulation of
wound heailng 
tumor Invasion
(L-6 I pTe
Inflammatory response \
Fig. 5 Role of fibroblasts in the regulation of proinflammatory IL- 
1, IL-6 and IL-8 levels induced by keratinocyte-derived IL-1: a 
working hypothesis. The activated keratinoeyte releases high 
amounts of IL -la  and low amounts of IL-6 and IL-8. The IL - la  
released markedly enhances the IL-8 and IL-6 production in neigh­
bouring fibroblasts. This may be a potent pathway for the amplifi­
cation of the signal and initiation of a more general inflammatory 
response. Fibroblasts may turn off this pathway by reducing the 
IL-1 activity via receptor-mediated uptake and degradation
cytokine production by turning off this pathway by reduc­
ing the IL-1 activity via a receptor-mediated uptake and 
degradation (schematically presented in Fig, 5). It remains 
to be established whether or not interactive circuits in skin 
tissue involving signalling by diffusible cytokines such as 
IL-1, IL-6 and IL-8 also occur in vivo.
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